SCHEMBL21282214

SCHEMBL21282214

CCOc1ccc2nc(Nc3ccc(OC)nc3)ccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 2/20 0.47
▸ MAPK8 P45983 1/20 0.47
▸ MAPK9 P45984 1/20 0.47
▸ MAPK10 P53779 1/20 0.47
▸ MEN1 O00255 2/20 0.44
▸ PABPC1 P11940 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ RAB9A P51151 1/20 0.43
▸ ACP1 P24666 1/20 0.43
▸ OXTR P30559 1/20 0.43
▸ SYK P43405 1/20 0.42
▸ MAPT P10636 2/20 0.42
▸ FYN P06241 2/20 0.41
▸ KDR P35968 1/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ PDGFRB P09619 2/20 0.40
▸ PDGFRA P16234 2/20 0.40
▸ IGF1R P08069 1/20 0.39
▸ PDE3B Q13370 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21282159 0.90 FYN (0.49) PIK3CAMAPK8MAPK9MAPK10MEN1
SCHEMBL21282160 0.87 MAPT (0.44) PIK3CAMAPK8MAPK9MAPK10MEN1
SCHEMBL21282164 0.85 PIK3CA (0.43) PIK3CAMAPK8MAPK9MAPK10MEN1
SCHEMBL21282210 0.83 KMT2A (0.47) PIK3CAMAPK8MAPK9MAPK10MEN1
SCHEMBL21282158 0.81 FYN (0.50) PIK3CAMAPK8MAPK9MAPK10MEN1
SCHEMBL21282189 0.81 MEN1 (0.46) PIK3CAMAPK8MAPK9MAPK10MEN1
SCHEMBL21282171 0.81 MEN1 (0.46) PIK3CAMAPK8MAPK9MAPK10MEN1
SCHEMBL21282217 0.77 MEN1 (0.69) PIK3CAMAPK8MAPK9MAPK10MEN1
SCHEMBL8902046 0.74 PDE3B (0.48) MEN1KMT2ARAB9AMAPTCYP11B1
SCHEMBL9881019 0.74 PDE3B (0.48) MEN1KMT2ARAB9AMAPTCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190256492-A1 ALPHA-SYNUCLEIN LIGANDS WASHINGTON UNIVERSITY (US) 2019-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256492-A1 ALPHA-SYNUCLEIN LIGANDS SNCA, PARK7, LRRK2 PIK3CA 4043/4885MAPK8 3908/4885MAPK9 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback